TuisBAX • NYSE
add
Baxter International Inc
Vorige sluiting
$35,70
Dagwisseling
$35,82 - $36,49
Jaarwisseling
$32,28 - $44,01
Markkapitalisasie
18,30 mjd USD
Gemiddelde volume
3,31 m
P/V-verhouding
7,37
Dividend-opbrengs
3,23%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 3,81 mjd | 2,83% |
Bedryfskoste | 1,09 mjd | 3,71% |
Netto inkomste | -314,00 m | -122,70% |
Netto winsgrens | -8,24 | -116,84% |
Wins per aandeel | 0,68 | 23,64% |
EBITDA | 653,00 m | -0,76% |
Effektiewe belastingkoers | -21,01% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 2,10 mjd | 21,66% |
Totale bates | 26,31 mjd | -5,64% |
Totale aanspreeklikheid | 18,60 mjd | -16,40% |
Totale ekwiteit | 7,71 mjd | — |
Uitstaande aandele | 510,18 m | — |
Prys om te bespreek | 2,38 | — |
Opbrengs op bates | 3,37% | — |
Opbrengs op kapitaal | 4,20% | — |
Kontantvloei
Netto kontantverandering
(USD) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -314,00 m | -122,70% |
Kontant van bedrywe | 115,00 m | -67,24% |
Kontant van beleggings | -91,00 m | 47,40% |
Kontant van finansiering | -936,00 m | -680,00% |
Netto kontantverandering | -934,00 m | -2 006,12% |
Beskikbare kontantvloei | 155,00 m | -27,19% |
Meer oor
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products. Baxter's BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis. Wikipedia
Gestig
1931
Hoofkwartier
Webwerf
Werknemers
60 000